Radiotherapy Positioning Devices Market Current and Future Industry Landscape Analysis 2027

The Radiotherapy positioning devices are used to position the patients during radiotherapy session. The patient positioning and immobilization are important during the radiation therapy treatment. The radiotherapy positioning devices are manufactured by the company understanding the need of the radiotherapy specialist and comfort of the patient.

The devices ensure ideal comfort and precision to the patient during therapy sessions. Cancer is a leading cause of death worldwide and is projected to rise with an estimated 11.5 million deaths in 2030. Cancer can be treated with surgery, chemotherapy, radiation therapy, hormone therapy, targeted therapy, precision medicine, immunotherapy and stem cell transplantation. Several clinical trials are ongoing to establish the potential of radiolabelled monoclonal antibody.

Radiotherapy is also used to treat patients suffering from non-Hodgkin B-cell lymphoma, and other sub-types of lymphoma or patients who do not respond to chemotherapy. Generally, no side effects are seen during the treatment. To ensure the efficient treatment process via radiotherapy, the comprehensive range of positioning radiotherapy devices are marketed across the globe

The radiotherapy positioning device manufacturers are aiming to improve the outcomes of the patient and healthcare specialist globally to provide high quality, unique and innovative patient-centric radiotherapy positioning devices. The patient positioning devices are accurate and provide maximum repositioning accuracy and patient stability by reducing both voluntary and involuntary patient movement.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5898

Increasing discretionary funding for cancer research by government and federal agencies, increase in Medicare coverage, rising prevalence of cancer among growing population, availability of new cancer treatment, and other devices accessory for the patients during the treatment process are some of the factors boosting the radiotherapy positioning devices market.

Radiotherapy Positioning Devices Market: Drivers and Restrains

According to World Health Organization, it is estimated that by 2030, about 23.6 million new cases of cancer will prevail worldwide. Governmental guidelines from American Society of Clinical Oncology and National Comprehensive Cancer Network (NCCN /ASCO) are providing help to healthcare professionals in the management and treatment of cancer patients.

In April 2016, the U.S. Government allocated US$ 5.2 Bn for the National Cancer Institute (NCI), a federal government agency, for cancer research and training. Good ergonomic design of the radiotherapy positioning devices will reduce the risk injuries among healthcare professionals, increasing workflow efficiencies, accurate delivery of prescribed radiation doses and others are some of the factors boosting the radiotherapy positioning devices market.

The budget increased by 5.3% as compared to the previous year. Insurance coverage and reimbursement issues, big companies are investing heavily in the cancer therapeutics and accessory devices used during the treatment process involving both time and money, and there is no guarantee that the product will get coverage, radiation risk to healthcare professionals and patients are some factors that may decline the growth of radiotherapy positioning devices

Request for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-5898

The radiotherapy positioning devices market is segmented into product type and end user. Based on the Product type, the global Radiotherapy Positioning Devices market is segmented into head, neck, and brain immobilization devices, thorax and breast immobilization device, pelvic immobilization devices and others. The positioning and immobilization devices provide small treatment volume, higher controlled doses and précised treatment options with higher cure rate.

Based on the end user, the market is segmented into the hospital, ambulatory surgical centres, and cancer research institutes. The rise in cancer patient population, funding by the governmental bodies, focus on acquisition and merger by various key manufacturers is attributed towards the growth of radiotherapy positioning devices market.